March 11, 2016
Marathon Pharmaceuticals Announces Nationwide Expanded Access Program for Patients with Duchenne Muscular Dystrophy (DMD)
Read More
October 3, 2012
Sarepta Therapeutics Clinical Trial Results with Eteplirsen Brings Kids with Duchenne Muscular Dystrophy Closer to Treatment
Read More
X